Template:Desirudin: Difference between revisions

Latest revision as of 04:13, 3 February 2014

Desirudin
IPRIVASK^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials
ClinicalTrials.gov

@@ Line 7: / Line 7: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Desirudin dosage and administration|Dosage and Administration]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Desirudin dosage forms and strengths|Dosage Forms and Strengths]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Desirudin contraindications|Contraindications]]
@@ Line 31: / Line 29: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Desirudin how supplied storage and handling|How Supplied/Storage and Handling]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Desirudin patient counseling information|Patient Counseling Information]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Desirudin labels and packages|Labels and Packages]]